US2009188002A1PendingUtilityA1
Artificial chromosomes and transchromosomic avians
Est. expiryMar 1, 2024(expired)· nominal 20-yr term from priority
C12N 2830/40C12N 9/22A01K 2217/05A01K 2227/40A01K 2267/01A01K 67/0275C12N 2800/204C12N 15/873C12N 2830/90A01K 2227/30C12N 15/8509C12N 2830/00C12N 2840/203C12N 2800/206C12N 2800/20
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention includes avians containing an artificial chromosome in their genome and methods of making the avians.
Claims
exact text as granted — not AI-modified1 . A method comprising:
isolating an artificial chromosome containing a centromere; injecting the artificial chromosome containing a centromere into an avian embryo; maintaining the embryo under conditions suitable for the embryo to develop and hatch as a chick; and maintaining the chick under conditions suitable to obtain an avian wherein the artificial chromosome containing a centromere is present in the genome of the avian.
2 . The method of claim 1 wherein the artificial chromosome contains a nucleotide sequence which can function as a marker.
3 . The method of claim 1 wherein the artificial chromosome contains heterochromatic DNA which can function as a marker.
4 . The method of claim 1 wherein the artificial chromosome is isolated by flow cytometry.
5 . The method of claim 4 wherein the flow cytometry is facilitated by a probe which is associated with the artificial chromosome.
6 . The method of claim 1 wherein the artificial chromosome is introduced into the avian embryo by injection.
7 . The method of claim 1 further comprising transferring the embryo to a recipient female avian.
8 . The method of claim 1 wherein the embryo is an early stage embryo.
9 . The method of claim 1 wherein the embryo is a stage I embryo.
10 . The method of claim 1 wherein the avian is a chicken.
11 . The method of claim 1 wherein the artificial chromosome comprises a heterologous recombination site.
12 . The method of claim 11 wherein the artificial chromosome comprises more than one heterologous recombination site.
13 . The method of claim 1 wherein the artificial chromosome comprises a heterologous coding sequence.
14 . The method of claim 13 wherein the heterologous coding sequence comprises a pharmaceutical protein coding sequence.
15 . The method of claim 13 wherein the heterologous coding sequence encodes a cytokine.
16 . The method of claim 13 wherein the heterologous coding sequence encodes a pharmaceutical protein selected from the group consisting of antibody and enzyme.
17 . The method of claim 1 wherein the artificial chromosome comprises a promoter.
18 . The method of claim 1 wherein the artificial chromosome comprises a promoter which functions in tubular gland cells.
19 . The method of claim 1 wherein the artificial chromosome comprises an IRES.
20 . The method of claim 1 further comprising obtaining an offspring from the avian wherein the offspring contains an artificial chromosome in its genome.
21 . An avian produced according to the method of claim 1 .
22 . A chicken produced according to the method of claim 1 .Join the waitlist — get patent alerts
Track US2009188002A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.